STRUCTURE THERAPEUTICS INC (GPCR) Stock Income Statement
NASDAQ:GPCR - US86366E1064 - ADR
20.08 USD
+0.78 (+4.04%)
20.2 USD
+0.12 (+0.6%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 219.66M | 158.23M | 102.78M | 52.56M | 37.70M | |||
| Research and Development | 163.66M | 108.81M | 70.10M | 36.19M | 29.11M | |||
| Selling, General, and Administrative Expenses | 56.00M | 49.41M | 32.67M | 16.37M | 8.59M | |||
| Operating Income | -219.66M | -158.23M | -102.78M | -52.56M | -37.70M | |||
| Interest Income/Expense | 41.17M | 36.01M | 13.39M | 1.26M | -122.00K | |||
| Income Before Taxes | -178.49M | -122.22M | -89.38M | -51.30M | -37.82M | |||
| Income Tax | 465.00K | 310.00K | 236.00K | 17.00K | 231.00K | |||
| Net Income | -178.95M | -122.53M | -89.62M | -52.84M | -43.77M | |||
| EBITDA | -218.56M | -157.24M | -102.48M | -52.28M | -37.62M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.12 | -2.33 | -2.44 | -1.44 | -1.20 | |||
| Non GAAP EPS | -3.18 | -1.66 | -2.13 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD